undamentalytics Newsletter

Nuwellis, Inc. revenue

Nuwellis, Inc.'s revenue was $8.3m in fiscal 2025, down 5.4% on the year before. Since fiscal 2013 ($59,000) it has grown at a compound 51.0% a year. Over the last twelve months it was $9.0m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nuwellis, Inc.: revenue history, annual
Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue059295591,2893,5534,9985,5117,4417,9218,5438,8648,7408,2709,013
Growth on the year before——+400.0%−80.0%+>999%+175.6%+40.7%+10.3%+35.0%+6.5%+7.9%+3.8%−1.4%−5.4%—
Gross profit—————7901,3282,8514,0574,4914,7554,9835,6765,1246,281
Gross margin—————22.2%26.6%51.7%54.5%56.7%55.7%56.2%64.9%62.0%69.7%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Nuwellis, Inc. $9.0m 8.4% 2.8%
Anbio Biotechnology $8.6m 5.6% —
Milestone Scientific Inc. $9.4m 3.7% -1.9%
Neuroone Medical Technologies Corp $9.5m 42.8% 94.9%
Work Medical Technology Group LTD $9.8m -14.4% —
Beyond Air, Inc. $7.7m 60.7% 122.7%

Compare with peers

Head to head: NNNN vs NUWEMLSS vs NUWENMTC vs NUWENUWE vs WOK

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nuwellis, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nuwellis, Inc.